Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Antimicrob Agents Chemother

Retrieve available abstracts of 216 articles:
HTML format
Text format



Single Articles


    September 2018
  1. TAN D, Htun HL, Koh J, Kanagasabai K, et al
    Comparative epidemiology of vancomycin-resistant enterococci colonization in an acute care hospital and its affiliated intermediate- and long-term care facilities in Singapore.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01507.
    PubMed     Text format     Abstract available


  2. DIAN S, Yunivita V, Ganiem AR, Pramaesya T, et al
    A double-blinded randomised placebo-controlled phase II trial to evaluate high dose rifampicin for tuberculous meningitis: a dose finding study.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01014.
    PubMed     Text format     Abstract available


  3. AURITI C, Ronchetti MP, Bersani I, Gennari F, et al
    Intrahepatic Administration of Amphotericin B Liposomal (Ambisome(R)) for the Management of a Liver Abscess from Candida albicans in a preterm infant.
    Antimicrob Agents Chemother. 2018 Sep 17. pii: AAC.01239.
    PubMed     Text format     Abstract available


  4. GUEST JM, Singh PK, Revankar SG, Chandrasekar PH, et al
    Isavuconazole for treatment of experimental fungal endophthalmitis caused by Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Sep 10. pii: AAC.01537.
    PubMed     Text format     Abstract available


  5. LEPAK AJ, Zhao M, Andes DR
    Pharmacodynamic Evaluation of Rezafungin (CD101) Against Candida auris in the Neutropenic Mouse Invasive Candidiasis Model.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.01572.
    PubMed     Text format     Abstract available


  6. DOMON H, Maekawa T, Yonezawa D, Nagai K, et al
    Mechanism of macrolide-induced inhibition of pneumolysin release involves impairment of autolysin release in macrolide-resistant Streptococcus pneumoniae.
    Antimicrob Agents Chemother. 2018 Sep 4. pii: AAC.00161.
    PubMed     Text format     Abstract available


    August 2018
  7. CARTER GP, Ussher JE, Goncalves Da Silva A, Baines SL, et al
    Genomic analysis of multi-resistant Staphylococcus capitis associated with neonatal sepsis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.00898.
    PubMed     Text format     Abstract available


  8. MILLER WR, Singh KV, Arias CA, Murray BE, et al
    Adjunctive Clavulanic Acid Abolishes the Cefazolin Inoculum Effect in an Experimental Rat Model of Methicillin-Sensitive Staphylococcus aureus Endocarditis.
    Antimicrob Agents Chemother. 2018 Aug 27. pii: AAC.01158.
    PubMed     Text format     Abstract available


  9. ROUARD C, Doucet-Populaire F, Guillet-Caruba C, Villet M, et al
    Deletion of one 23S rDNA (rrl) copy contributes to the development of resistance to linezolid in Staphylococcus warneri.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01139.
    PubMed     Text format     Abstract available


  10. KENIYA MV, Sabherwal M, Wilson RK, Woods MA, et al
    Crystal structures of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provide tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01134.
    PubMed     Text format     Abstract available


  11. UKAI Y, Kuroiwa M, Kurihara N, Naruse H, et al
    Contributions of yap1 mutation and subsequent atrF upregulation to voriconazole resistance in Aspergillus flavus.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01216.
    PubMed     Text format     Abstract available


  12. KENIYA MV, Ruma YN, Tyndall JDA, Monk BC, et al
    Heterologous expression of full-length lanosterol 14alpha-demethylases of prominent fungal pathogens Candida albicans and Candida glabrata provides tools for antifungal discovery.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01131.
    PubMed     Text format     Abstract available


  13. CAO R, Teskey G, Islamoglu H, Abrahem R, et al
    Characterizing the Effects of Glutathione as an Immunoadjuvant in the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01132.
    PubMed     Text format     Abstract available


  14. PAUL RA, Rudramurthy SM, Dhaliwal M, Singh P, et al
    Voriconazole resistance in clinical and environmental isolates of Aspergillus flavus - frequency and investigation into the role of multidrug efflux pumps.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01022.
    PubMed     Text format     Abstract available


  15. ALFARISI O, Mave V, Gaikwad S, Sahasrabudhe T, et al
    The effect of diabetes mellitus on the pharmacokinetics and pharmacodynamics of tuberculosis treatment.
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.01383.
    PubMed     Text format     Abstract available


  16. LUPIEN A, Vocat A, Foo CS, Blattes E, et al
    An optimized background regimen for treatment of active tuberculosis with the next-generation benzothiazinone Macozinone (PBTZ169).
    Antimicrob Agents Chemother. 2018 Aug 20. pii: AAC.00840.
    PubMed     Text format     Abstract available


  17. WIEDERHOLD NP, Xu X, Wang A, Najvar LK, et al
    In Vivo Efficacy of VT-1129 against Experimental Cryptococcal Meningitis with the Use of a Loading Dose-Maintenance Dose Administration Strategy.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01315.
    PubMed     Text format     Abstract available


  18. WALL G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, et al
    Screening a Repurposing Library for Inhibitors of Multi-Drug Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.01084.
    PubMed     Text format     Abstract available


  19. HO K, Huo W, Pas S, Dao R, et al
    Loss of function mutations in epaR confer resistance to phage NPV1 infection in Enterococcus faecalis OG1RF.
    Antimicrob Agents Chemother. 2018 Aug 13. pii: AAC.00758.
    PubMed     Text format     Abstract available


  20. KANDLER JL, Mercante AD, Dalton TL, Ezewudo MN, et al
    Validation of novel Mycobacterium tuberculosis isoniazid resistance mutations not detectable by common molecular tests.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00974.
    PubMed     Text format     Abstract available


  21. ISLA G, Leonardelli F, Tiraboschi IN, Refojo N, et al
    First clinical isolation of an azole-resistant Aspergillus fumigatus harboring a TR46/Y121F/T289A mutation in South America.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.00872.
    PubMed     Text format     Abstract available


  22. HEALEY KR, Kordalewska M, Jimenez Ortigosa C, Singh A, et al
    Limited ERG11 mutations identified in isolates of Candida auris directly contribute to reduced azole susceptibility.
    Antimicrob Agents Chemother. 2018 Aug 6. pii: AAC.01427.
    PubMed     Text format     Abstract available


  23. KOSER CU, Heyckendorf J, Andres S, Olaru ID, et al
    Reply to Dookie et al., "Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  24. DOOKIE N, Naidoo K, Padayatchi N
    Whole-Genome Sequencing To Guide the Selection of Treatment for Drug-Resistant Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    July 2018
  25. JAGIELSKI T, Bakula Z, Brzostek A, Minias A, et al
    Characterization of mutations conferring resistance to rifampicin in Mycobacterium tuberculosis clinical strains.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.01093.
    PubMed     Text format     Abstract available


  26. WEIKUM J, Ritzmann N, Jelden N, Klockner A, et al
    Sulfide protects Staphylococcus aureus from aminoglycoside antibiotics but cannot be regarded as a general defense mechanism against antibiotics.
    Antimicrob Agents Chemother. 2018 Jul 30. pii: AAC.00602.
    PubMed     Text format     Abstract available


  27. KIM NH, Park WB, Cho JE, Choi YJ, et al
    Effects of phage endolysin SAL200 combined with antibiotics on Staphylococcus aureus infection.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.00731.
    PubMed     Text format     Abstract available


  28. RAZ A, Serrano A, Thaker M, Alston T, et al
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01056.
    PubMed     Text format     Abstract available


  29. WHALEY SG, Zhang Q, Caudle KE, Rogers PD, et al
    Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jul 23. pii: AAC.01070.
    PubMed     Text format     Abstract available


  30. PELOQUIN CA, Phillips PPJ, Mitnick CD, Eisenach K, et al
    Increased Doses Lead to Higher Drug Exposures of Levofloxacin for the Treatment of Tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00770.
    PubMed     Text format     Abstract available


  31. ZHAO Y, Lee MH, Paderu P, Lee A, et al
    Significantly improved pharmacokinetics enhances in vivo efficacy of APX001 against echinocandin and multidrug resistant Candida isolates in a mouse model of invasive candidiasis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00425.
    PubMed     Text format     Abstract available


  32. YAN Q, Karau MJ, Raval YS, Patel R, et al
    Evaluation of Oritavancin in Combination with Rifampin, Gentamicin or Linezolid Against Prosthetic Joint Infection-Associated Methicillin-Resistant Staphylococcus aureus Biofilms by Time-Kill Assays.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00943.
    PubMed     Text format     Abstract available


  33. KANWAR A, Cadnum JL, Jencson AL, Donskey CJ, et al
    Impact of Antibiotic Treatment on the Burden of Nasal Staphylococcus aureus Among Hospitalized Patients.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00609.
    PubMed     Text format     Abstract available


  34. KIDD JM, Abdelraouf K, Asempa TE, Humphries RM, et al
    Pharmacodynamics of Daptomycin Against Enterococcus faecium and Enterococcus faecalis in the Murine Thigh Infection Model.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00506.
    PubMed     Text format     Abstract available


  35. PITON J, Vocat A, Lupien A, Foo C, et al
    Structure-based drug design and characterization of sulfonyl-piperazine benzothiazinone inhibitors of DprE1 from Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 16. pii: AAC.00681.
    PubMed     Text format     Abstract available


  36. PIETERMAN ED, Te Brake LHM, de Knegt GJ, van der Meijden A, et al
    Assessment of the additional value of verapamil to a moxifloxacin and linezolid combination regimen in a murine tuberculosis model.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01354.
    PubMed     Text format     Abstract available


  37. WIEDERHOLD NP, Najvar LK, Garvey EP, Brand SR, et al
    The Fungal Cyp-51 Inhibitor VT-1129 is Efficacious in an Experimental Model of Cryptococcal Meningitis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.01071.
    PubMed     Text format     Abstract available


  38. HOYER AR, Johnson CJ, Hoyer MR, Kernien JF, et al
    Echinocandin treatment of Candida albicans biofilms enhances neutrophil extracellular trap (NET) formation.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00797.
    PubMed     Text format     Abstract available


  39. AGUILAR-PEREZ C, Gracia B, Rodrigues L, Vitoria A, et al
    Synergy between circular bacteriocin AS-48 and ethambutol against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jul 9. pii: AAC.00359.
    PubMed     Text format     Abstract available


  40. DANION F, Jullien V, Rouzaud C, Abdel Fattah M, et al
    Is it time for systematic voriconazole pharmacogenomic investigation for central nervous system aspergillosis?
    Antimicrob Agents Chemother. 2018 Jul 2. pii: AAC.00705.
    PubMed     Text format     Abstract available


  41. PARDOS DE LA GANDARA M, Borges V, Chung M, Milheirico C, et al
    Correction for Pardos de la Gandara et al., "Genetic Determinants of High-Level Oxacillin Resistance in Methicillin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    June 2018
  42. TAJ-ALDEEN SJ, Salah H, Perez WB, Almaslamani M, et al
    Molecular analysis of resistance and detection of non-wild type strains using ECV values of Etest for amphotericin B and echinocandins for bloodstream Candida infections from a tertiary hospital in Qatar.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00214.
    PubMed     Text format     Abstract available


  43. CAMPEAU SA, Schuetz AN, Kohner P, Arias CA, et al
    Variability of daptomycin minimum inhibitory concentrations for Enterococcus faecium when measured by reference broth microdilution and gradient diffusion tests.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00745.
    PubMed     Text format     Abstract available


  44. LEE H, Yoon EJ, Kim D, Kim JW, et al
    Ceftaroline resistance by clone-specific polymorphism in penicillin-binding protein 2a of methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00485.
    PubMed     Text format     Abstract available


  45. RANCOITA PMV, Cugnata F, Gibertoni Cruz AL, Borroni E, et al
    Validating a 14-drug microtitre plate containing bedaquiline and delamanid for large-scale research susceptibility testing of Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Jun 25. pii: AAC.00344.
    PubMed     Text format     Abstract available


  46. HORITA Y, Alsultan A, Kwara A, Antwi S, et al
    Evaluation of the Adequacy of WHO revised Dosages of the First-Line Anti-Tuberculosis Drugs in Children with Tuberculosis using Population Pharmacokinetic Modeling and Simulations.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00008.
    PubMed     Text format     Abstract available


  47. UMEYAMA T, Hayashi Y, Shimosaka H, Inukai T, et al
    Cas9/CRISPR genome editing to demonstrate the contribution of Cyp51A Gly138Ser to azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00894.
    PubMed     Text format     Abstract available


  48. STOTT KE, Beardsley J, Kolamunnage-Dona R, Santoyo Castelazo A, et al
    Population pharmacokinetics and cerebrospinal fluid penetration of fluconazole in adults with cryptococcal meningitis.
    Antimicrob Agents Chemother. 2018 Jun 18. pii: AAC.00885.
    PubMed     Text format     Abstract available


  49. TRUONG-BOLDUC QC, Wang Y, Hooper DC
    Tet38 Efflux Pump Contributes to Fosfomycin Resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00927.
    PubMed     Text format     Abstract available


  50. WANG SK, Gilchrist A, Loukitcheva A, Plotkin BJ, et al
    The Prevalence of a Cefazolin Inoculum Effect Associated with blaZ Gene Types Among Methicillin-Susceptible Staphylococcus aureus Isolates from Four Major Medical Centers in Chicago.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00382.
    PubMed     Text format     Abstract available


  51. DABAS Y, Xess I, Bakshi S, Mahapatra M, et al
    "Emergence of azole resistant Aspergillus fumigatus from immunocompromised hosts in India".
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.02264.
    PubMed     Text format     Abstract available


  52. DU PRE S, Beckmann N, Almeida MC, Sibley GEM, et al
    The effect of the novel antifungal drug F901318 (Olorofim) on the growth and viability of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Jun 11. pii: AAC.00231.
    PubMed     Text format     Abstract available


  53. SIMITSOPOULOU M, Chlichlia K, Kyrpitzi D, Walsh TJ, et al
    Pharmacodynamic and immunomodulatory effects of micafungin on host responses against biofilms of Candida parapsilosis in comparison to those of Candida albicans.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00478.
    PubMed     Text format     Abstract available


  54. DE MIRANDA SILVA C, Hajihosseini A, Myrick J, Nole J, et al
    Effect of Linezolid plus Bedaquiline against Mycobacterium tuberculosis in Log-Phase, Acid-Phase and Non-Replicating-Persister (NRP)-Phase in an In vitro Assay.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00856.
    PubMed     Text format     Abstract available


  55. CEBALLOS S, Kim C, Ding D, Mobashery S, et al
    Activities of oxadiazole antibacterials against Staphylococcus aureus and other Gram-positive bacteria.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00453.
    PubMed     Text format     Abstract available


  56. DRUSANO GL, Myrick J, Maynard M, Nole J, et al
    Linezolid Kills Acid Phase and Non-replicative Persister Phase Mycobacterium tuberculosis in a Hollow Fiber Infection Model.
    Antimicrob Agents Chemother. 2018 Jun 4. pii: AAC.00221.
    PubMed     Text format     Abstract available


    May 2018
  57. SAVAGE KA, Parquet MDC, Allan DS, Davidson RJ, et al
    Iron restriction to clinical isolates of Candida albicans by the novel chelator DIBI inhibits growth and increases sensitivity to azoles in vitro and in vivo in a murine model of experimental vaginitis.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.02576.
    PubMed     Text format     Abstract available


  58. ZONG Z, Jing W, Shi J, Wen S, et al
    Comparison of in vitro activity and MIC distributions between the novel oxazolidinone delpazolid and linezolid against multidrug-resistant and extensively drug-resistant Mycobacterium tuberculosis in China.
    Antimicrob Agents Chemother. 2018 May 29. pii: AAC.00165.
    PubMed     Text format     Abstract available


  59. JAHANBAKHSH S, Singh NB, Yim J, Rose WE, et al
    Evaluation of Telavancin Alone and Combined with Ceftaroline or Rifampin against Methicillin-Resistant Staphylococcus aureus (MRSA) in an in vitro Biofilm Model.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00567.
    PubMed     Text format     Abstract available


  60. SHOEN C, DeStefano M, Hafkin B, Cynamon M, et al
    In vitro and in vivo activity of contezolid (MRX-I) against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00493.
    PubMed     Text format     Abstract available


  61. GOEMAERE B, Lagrou K, Spriet I, Hendrickx M, et al
    Clonal spread in Candida glabrata bloodstream isolates and fluconazole resistance affected by prolonged exposure: a 12-year single-center study in Belgium.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00591.
    PubMed     Text format     Abstract available


  62. BROWN GANDT A, Griffith EC, Lister IM, Billings LL, et al
    In vivo and in vitro effects of a ClpP activating antibiotic against vancomycin resistant enterococci.
    Antimicrob Agents Chemother. 2018 May 21. pii: AAC.00424.
    PubMed     Text format     Abstract available


  63. KEBRIAEI R, Rice SA, Singh KV, Stamper KC, et al
    Efficacy of Daptomycin Monotherapy and In Combination with beta-lactams for Daptomycin-Susceptible Enterococcus faecium Harboring LiaSR Substitutions: Influence of The Inoculum Effect.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00315.
    PubMed     Text format     Abstract available


  64. POELMANS J, Himmelreich U, Vanherp L, Zhai L, et al
    A multimodal imaging approach enables in vivo assessment of antifungal treatment in a mouse model of invasive pulmonary aspergillosis.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00240.
    PubMed     Text format     Abstract available


  65. LUO J, Yu X, Jiang G, Fu Y, et al
    In Vitro Activity of Clofazimine against Non-tuberculous Mycobacteriaisolated in Beijing, China.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00072.
    PubMed     Text format     Abstract available


  66. LOPEZ-SANCHEZ A, Perez-Cantero A, Torrado-Salmeron C, Martin-Vicente A, et al
    Experimental Amphotericin B-Deoxycholate formulations for pulmonary aspergillosis: efficacy, biodistribution and nephrotoxicity.
    Antimicrob Agents Chemother. 2018 May 14. pii: AAC.00489.
    PubMed     Text format     Abstract available


  67. STOTT KE, Beardsley J, Whalley S, Kibengo FM, et al
    Amphotericin B Deoxycholate in adults with Cryptococcal Meningitis; a Population Pharmacokinetic Model and Meta-Analysis of Outcomes.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.02526.
    PubMed     Text format     Abstract available


  68. BOUDJEMAA R, Cabriel C, Dubois-Brissonnet F, Bourg N, et al
    Failure of daptomycin to kill Staphylococcus aureus: impact of bacterial membrane fatty acid composition.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00023.
    PubMed     Text format     Abstract available


  69. GUO H, Zhou L, He Y, Gao C, et al
    Natamycin and Azithromycin are Synergistic in vitro against Ocular Pathogenic Aspergillus flavus species complex and Fusarium solani species complex Isolates.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00077.
    PubMed     Text format     Abstract available


  70. AMMERMAN NC, Swanson RV, Bautista EM, Almeida DV, et al
    Impact of Clofazimine Dosing on Treatment-Shortening of the First-Line Regimen in a Mouse Model of Tuberculosis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00636.
    PubMed     Text format     Abstract available


  71. TIWARI KB, Gatto C, Walker S, Wilkinson BJ, et al
    Targocil-exposure of Staphylococcus aureus Blocks Translocation of the Major Autolysin Atl Across the Membrane Resulting in a Significant Decrease in Autolysis.
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00323.
    PubMed     Text format     Abstract available


  72. KASPAR U, de Haro Sautto JA, Molinaro S, Peters G, et al
    The novel phage-derived antimicrobial agent HY-133 is active against livestock-associated methicillin-resistant Staphylococcus aureus (LA-MRSA).
    Antimicrob Agents Chemother. 2018 May 7. pii: AAC.00385.
    PubMed     Text format     Abstract available


  73. KAUFMANN SHE
    Indole Propionic Acid: a Small Molecule Links between Gut Microbiota and Tuberculosis.
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    April 2018
  74. BUTTS A, Reitler P, Ge W, Fortwendel JR, et al
    Commonly used oncology drugs decrease antifungal effectiveness against Candida and Aspergillus species.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00504.
    PubMed     Text format     Abstract available


  75. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, Bouza E, et al
    Resistance to echinocandins in Candida can be detected by performing the Etest directly on blood culture samples.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00162.
    PubMed     Text format     Abstract available


  76. SIALA W, Rodriguez-Villalobos H, Fernandes P, Tulkens PM, et al
    Activity of combinations of antistaphylococcal antibiotics with fusidic acid against staphylococcal biofilms in in vitro static and dynamic models.
    Antimicrob Agents Chemother. 2018 Apr 30. pii: AAC.00598.
    PubMed     Text format     Abstract available


  77. SHI W, Chen J, Zhang S, Zhang W, et al
    Identification of novel mutations in LprG (rv1411c), rv0521,rv3630, rv0010c, ppsC,cyp128 associated with pyrazinoic acid/pyrazinamide resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00430.
    PubMed     Text format     Abstract available


  78. BUTLER-LAPORTE G, Lee TC, Cheng MP
    Increasing Rates of Penicillin Sensitivity in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 23. pii: AAC.00680.
    PubMed     Text format     Abstract available


  79. BOOT M, Commandeur S, Subudhi AK, Bahira M, et al
    Accelerating early anti-tuberculosis drug discovery by creating mycobacterial indicator strains that predict mode of action.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00083.
    PubMed     Text format     Abstract available


  80. ZHENG H, Williams JT, Coulson GB, Haiderer ER, et al
    HC2091 kills Mycobacterium tuberculosis by targeting the MmpL3 mycolic acid transporter.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02459.
    PubMed     Text format     Abstract available


  81. BEN-SHMUEL A, Glinert I, Sittner A, Bar-David E, et al
    Treating Anthrax-Induced Meningitis in Rabbits.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00298.
    PubMed     Text format     Abstract available


  82. LIU Y, Pertinez H, Davies GR, Gillespie SH, et al
    Moxifloxacin replacement in contemporary tuberculosis drug regimens is ineffective against persistent Mycobacterium tuberculosis: Novel insights from the Cornell mouse model.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00190.
    PubMed     Text format     Abstract available


  83. LYONS MA
    Modeling and Simulation of Pretomanid Pharmacokinetics in Pulmonary Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.02359.
    PubMed     Text format     Abstract available


  84. STEFAN MA, Ugur FS, Garcia GA
    SOURCE OF THE FITNESS DEFECT IN RIFAMYCIN-RESISTANT M. TUBERCULOSIS RNA POLYMERASE AND THE MECHANISM OF COMPENSATION BY MUTATIONS IN THE beta'-SUBUNIT.
    Antimicrob Agents Chemother. 2018 Apr 16. pii: AAC.00164.
    PubMed     Text format     Abstract available


  85. KORDALEWSKA M, Lee A, Park S, Berrio I, et al
    Understanding echinocandin resistance in the emerging pathogen Candida auris.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00238.
    PubMed     Text format     Abstract available


  86. GARCIA-RUBIO R, Alcazar-Fuoli L, Monteiro MC, Monzon S, et al
    Aspergillus fumigatus cyp51A polymorphisms, an insight on their significance.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.00241.
    PubMed     Text format     Abstract available


  87. LASKARIS P, Vicentefranqueira R, Helynck O, Jouvion G, et al
    A novel polyaminocarboxylate compound to treat murine pulmonary aspergillosis by interfering with zinc metabolism.
    Antimicrob Agents Chemother. 2018 Apr 9. pii: AAC.02510.
    PubMed     Text format     Abstract available


  88. GHANNOUM M, Long L, Larkin EL, Isham N, et al
    SCY-078, a Novel Oral Glucan Synthase Inhibitor, for the Treatment of Invasive Aspergillosis: Evaluation of Antifungal Activity Singly and in Combination.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00244.
    PubMed     Text format     Abstract available


  89. LI JL, Yang N, Huang L, Chen D, et al
    Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02260.
    PubMed     Text format     Abstract available


  90. BARMAN TK, Kumar M, Mathur T, Namba E, et al
    In vitro and in vivo activities of DS-2969b, a novel GyrB inhibitor, and its water-soluble prodrug, DS11960558, against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02556.
    PubMed     Text format     Abstract available


  91. LAMONTAGNE BOULET M, Isabelle C, Guay I, Brouillette E, et al
    Tomatidine, a lead antibiotic molecule that targets Staphylococcus aureus ATP synthase subunit C.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02197.
    PubMed     Text format     Abstract available


  92. LI FJ, Palmer KL
    EfrEF and the transcription regulator ChlR are required for chlorhexidine stress response in Enterococcus faecalis V583.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00267.
    PubMed     Text format     Abstract available


  93. SINGH A, Healey KR, Yadav P, Upadhyaya G, et al
    Absence of azole or echinocandin resistance in Candida glabrata isolates in India despite background prevalence of strains with defects in DNA mismatch repair pathway.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00195.
    PubMed     Text format     Abstract available


  94. GSALLER F, Furukawa T, Carr PD, Rash B, et al
    The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02593.
    PubMed     Text format     Abstract available


  95. BASSO V, Garcia A, Tran DQ, Schaal JB, et al
    Fungicidal potency and mechanisms of theta-defensins against multi-drug resistant Candida species.
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.00111.
    PubMed     Text format     Abstract available


  96. GARCIA-DE-LA-MARIA C, Gasch O, Garcia-Gonzalez J, Soy D, et al
    The Combination of Daptomycin plus Fosfomycin has Synergistic, Potent and Rapid Bactericidal Activity against Methicillin-Resistant Staphylococcus aureus (MRSA) in a Rabbit Model of Experimental Endocarditis (EE).
    Antimicrob Agents Chemother. 2018 Apr 2. pii: AAC.02633.
    PubMed     Text format     Abstract available


  97. YANG F, Zhang L, Wakabayashi H, Myers J, et al
    Correction for Yang et al., "Tolerance to Caspofungin in Candida albicans Is Associated with at Least Three Distinctive Mechanisms That Govern Expression of FKS Genes and Cell Wall Remodeling".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  98. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Erratum for Chen et al., "Chemogenomic Profiling of the Fungal Pathogen Candida albicans".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    March 2018
  99. CHEN CL, Cheng MH, Kuo CF, Cheng YL, et al
    Dextromethorphan Attenuates NADPH Oxidase-regulated GSK-3beta and NF-kappaB Activation and Reduces Nitric Oxide Production in Group A Streptococcal Infection.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02045.
    PubMed     Text format     Abstract available


  100. HIRAYAMA T, Miyazaki T, Yamagishi Y, Mikamo H, et al
    Clinical and Microbiological Characteristics of Candida guilliermondii and Candida fermentati.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02528.
    PubMed     Text format     Abstract available


  101. ESCHENAUER GA, Carver PL, Patel TS, Lin SW, et al
    Survival in Patients with Candida glabrata Bloodstream Infections is Associated with Fluconazole Dose.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.02566.
    PubMed     Text format     Abstract available


  102. HOU X, Xiao M, Wang H, Yu SY, et al
    Profiling of PDR1 and MSH2 in Candida glabrata Bloodstream Isolates from a Multi-Center Study in China.
    Antimicrob Agents Chemother. 2018 Mar 26. pii: AAC.00153.
    PubMed     Text format     Abstract available


  103. BADER JC, Lakota EA, Flanagan S, Ong V, et al
    Overcoming the Resistance Hurdle: PK-PD Target Attainment Analyses of Rezafungin (CD101) for Candida albicans and Candida glabrata.
    Antimicrob Agents Chemother. 2018 Mar 19. pii: AAC.02614.
    PubMed     Text format     Abstract available


  104. LUTHER MK, Parente DM, Caffrey AR, Daffinee K, et al
    Clinical and genetic risk factors for biofilm-forming Staphylococcus aureus.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02252.
    PubMed     Text format     Abstract available


  105. TOMAS ME, Mana TSC, Wilson BM, Nerandzic MM, et al
    Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota that Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.02237.
    PubMed     Text format     Abstract available


  106. KOK EY, Vallejo JG, Sommer LM, Rosas L, et al
    Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus aureus Acute Hematogenous Osteoarticular Infections in Children.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00084.
    PubMed     Text format     Abstract available


  107. SMITH JR, Yim J, Rice S, Stamper K, et al
    The combination of tedizolid and daptomycin against methicillin-resistant Staphylococcus aureus in an in vitro model of simulated endocardial vegetations.
    Antimicrob Agents Chemother. 2018 Mar 12. pii: AAC.00101.
    PubMed     Text format     Abstract available


  108. CHEN Y, Li Z, Han X, Tian S, et al
    Elevated MIC values to imidazole drugs among Aspergillus fumigatus isolates with TR34/L98H/S297T/F495I mutation.
    Antimicrob Agents Chemother. 2018 Mar 5. pii: AAC.01549.
    PubMed     Text format     Abstract available


  109. MERCER DK, Katvars LK, Hewitt F, Smith DW, et al
    Correction for Mercer et al., "NP108, an Antimicrobial Polymer with Activity against Methicillin- and Mupirocin-Resistant Staphylococcus aureus".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


  110. ARIAS CA, Reyes J, Carvajal LP, Rincon S, et al
    Erratum for Arias et al., "A Prospective Cohort Multicenter Study of Molecular Epidemiology and Phylogenomics of Staphylococcus aureus Bacteremia in Nine Latin American Countries".
    Antimicrob Agents Chemother. 2018;62.
    PubMed     Text format    


    February 2018
  111. GUIRAO-ABAD JP, Sanchez-Fresneda R, Machado F, Arguelles JC, et al
    MICAFUNGIN ENHANCES THE HUMAN MACROPHAGE RESPONSE TO Candida albicans THROUGH beta-GLUCAN EXPOSURE.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.02161.
    PubMed     Text format     Abstract available


  112. LU Z, Jia X, Chen Y, Han X, et al
    Identification and Characterization of Key Charged Residues in the Cofilin Protein Involved in Azole Susceptibility, Apoptosis, and Virulence of Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01659.
    PubMed     Text format     Abstract available


  113. GUPTA R, Felix CR, Akerman MP, Akerman KJ, et al
    Gold(III) macrocycles and chelates targeting Mycobacterium tuberculosis and Mycobacterium abscessus: evidence for inhibition of topoisomerase 1A.
    Antimicrob Agents Chemother. 2018 Feb 26. pii: AAC.01696.
    PubMed     Text format     Abstract available


  114. BERKOW EL, Nunnally NS, Bandea A, Kuykendall R, et al
    Detection of TR34/L98H Cyp51A mutation through passive surveillance for azole-resistant Aspergillus fumigatus in the US, 2015-2017.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02240.
    PubMed     Text format     Abstract available


  115. CHEN C, Gardete S, Jansen RS, Shetty A, et al
    Verapamil targets membrane energetics in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02107.
    PubMed     Text format     Abstract available


  116. HEMANTH KUMAR AK, Kumar A, Kannan T, Bhatia R, et al
    Pharmacokinetics of second-line anti-tuberculosis drugs in children with multidrug-resistant tuberculosis in India.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02410.
    PubMed     Text format     Abstract available


  117. MELETIADIS J, Siopi M, Tsakris A, Mouton JW, et al
    A new marker of echinocandins activity in an in vitro PK/PD model correlates with an animal model of Aspergillus fumigatus infection.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.02322.
    PubMed     Text format     Abstract available


  118. WEINER M, Gelfond J, Johnson-Pais TL, Engle M, et al
    Elevated Plasma Moxifloxacin Concentrations and SLCO1B1 g.-11187G>A Polymorphism in Adults with Pulmonary Tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 20. pii: AAC.01802.
    PubMed     Text format     Abstract available


  119. ZUUR MA, Ghimire S, Bolhuis MS, Wessels AMA, et al
    The Pharmacokinetics of 2000 mg Ertapenem in Tuberculosis Patients.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02250.
    PubMed     Text format     Abstract available


  120. COLLEY T, Sehra G, Chowdhary A, Alanio A, et al
    In Vitro and In Vivo Efficacy of a Novel and Long Acting Fungicidal Azole, PC1244 on Aspergillus fumigatus Infection.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01941.
    PubMed     Text format     Abstract available


  121. MURATA M, Kosai K, Yamauchi S, Sasaki D, et al
    In vitro activity of lascufloxacin against Streptococcus pneumoniae with mutations in the quinolone resistance-determining regions (QRDRs).
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.01971.
    PubMed     Text format     Abstract available


  122. IMBERT S, Normand AC, Ranque S, Costa JM, et al
    Species identification and in vitro-antifungal susceptibility of Aspergillus terreus species complex clinical isolates: a French multicentre study.
    Antimicrob Agents Chemother. 2018 Feb 12. pii: AAC.02315.
    PubMed     Text format     Abstract available


  123. CHEN Y, Yuan Z, Shen X, Wu J, et al
    Time to Multidrug-Resistant Tuberculosis Treatment Initiation in Association with Treatment Outcomes in Shanghai, China.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02259.
    PubMed     Text format     Abstract available


  124. SAO EMANI C, Williams MJ, Wiid I, Baker B, et al
    Compounds with potential activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02236.
    PubMed     Text format     Abstract available


  125. ESPINEL-INGROFF A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, et al
    Posaconazole MIC distributions for Aspergillus fumigatus SC by four methods: Impact of Cyp51A mutations on estimation of epidemiological cutoff values (ECVs/ECOFFs).
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01916.
    PubMed     Text format     Abstract available


  126. KHAN Z, Ahmad S, Mokaddas E, Meis JF, et al
    Development of echinocandin resistance in Candida tropicalis following short-term exposure to caspofungin for empiric therapy.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01926.
    PubMed     Text format     Abstract available


  127. LYSKOVA P, Hubka V, Svobodova L, Barrs V, et al
    Antifungal susceptibility of the Aspergillus viridinutans complex: comparison of two in vitro methods.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01927.
    PubMed     Text format     Abstract available


  128. ELJAALY K, Alshehri S, Erstad BL
    Safety of Anti-Staphylococcal Penicillins versus Cefazolin: A Systematic Review and Meta-Analysis.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.01816.
    PubMed     Text format     Abstract available


  129. RIAT A, Plojoux J, Gindro K, Schrenzel J, et al
    Azole resistance of Aspergillus fumigatus isolates from the environment and the clinic in Switzerland.
    Antimicrob Agents Chemother. 2018 Feb 5. pii: AAC.02088.
    PubMed     Text format     Abstract available


    January 2018
  130. IDELEVICH EA, Kriegeskorte A, Schleimer N, Peters G, et al
    In Vitro Susceptibility of Clinical Staphylococcus aureus Small Colony Variants to beta-Lactam and Non-ss-Lactam Antibiotics.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02532.
    PubMed     Text format     Abstract available


  131. WANG Q, Pang Y, Jing W, Liu Y, et al
    Clofazimine for Treatment of Pulmonary Extensively Drug-Resistant Tuberculosis in China.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02149.
    PubMed     Text format     Abstract available


  132. HUO F, Luo J, Shi J, Zong Z, et al
    Increasing Prevalence of Rifampicin-Resistant Mycobacterium tuberculosis is Associated with the Transmission of Strains Harboring Compensatory Mutations in China: A 10-year Comparative Analysis.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02303.
    PubMed     Text format     Abstract available


  133. ZHAO M, Lepak AJ, VanScoy B, Bader JC, et al
    In Vivo Pharmacokinetics and Pharmacodynamics of APX001 against Candida spp. in a Neutropenic Disseminated Candidiasis Mouse Model.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02542.
    PubMed     Text format     Abstract available


  134. ADANI S, Bhowmick T, Weinstein MP, Narayanan N, et al
    Clinical Outcomes of Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia Treated with Vancomycin at an Institution with Suppressed MIC Reporting: Impact of Vancomycin MIC.
    Antimicrob Agents Chemother. 2018 Jan 29. pii: AAC.02512.
    PubMed     Text format     Abstract available


  135. PEYRUSSON F, Tulkens PM, Van Bambeke F
    Cellular pharmacokinetics and intracellular activity of gepotidacin against Staphylococcus aureus with different resistance phenotypes in models of cultured phagocytic cells.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02245.
    PubMed     Text format     Abstract available


  136. SUWUNNAKORN S, Wakabayashi H, Kordalewska M, Perlin DS, et al
    FKS2 and FKS3 genes of opportunistic human pathogen Candida albicans influence echinocandin susceptibility.
    Antimicrob Agents Chemother. 2018 Jan 22. pii: AAC.02299.
    PubMed     Text format     Abstract available


  137. CHACKO K, Sullivan M, Beckford C, Altman D, et al
    The genetic basis of emerging vancomycin, linezolid, and daptomycin heteroresistance in a case of persistent Enterococcus faecium bacteremia.
    Antimicrob Agents Chemother. 2018 Jan 16. pii: AAC.02007.
    PubMed     Text format     Abstract available


  138. ORTINES RV, Liu H, Cheng LI, Cohen TS, et al
    Neutralizing alpha-toxin accelerates healing of Staphylococcus aureus-infected wounds in normal and diabetic mice.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02288.
    PubMed     Text format     Abstract available


  139. SHARMA C, Kumar R, Kumar N, Masih A, et al
    Investigation of multiple resistance mechanisms in voriconazole resistant Aspergillus flavus clinical isolates from a chest hospital surveillance in Delhi, India.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01928.
    PubMed     Text format     Abstract available


  140. GARNAUD C, Garcia-Oliver E, Wang Y, Maubon D, et al
    The Rim pathway mediates antifungal tolerance in Candida albicans through newly identified Rim101 transcriptional targets including Hsp90 and Ipt1.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01785.
    PubMed     Text format     Abstract available


  141. LONG N, Zeng L, Qiao S, Li L, et al
    Aspergillus fumigatus Afssn3-Afssn8 Pair Reverse regulates Azole Resistance by Conferring Extracellular Polysaccharide, Sphingolipid Pathway Intermediates and Efflux Pumps to Biofilm.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01978.
    PubMed     Text format     Abstract available


  142. YU SJ, Chang YL, Chen YL
    Deletion of ADA2 increases antifungal drug susceptibility and virulence in Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01924.
    PubMed     Text format     Abstract available


  143. DIJKSTRA JA, van der Laan T, Akkerman OW, Bolhuis MS, et al
    In vitro drug susceptibility of Mycobacterium tuberculosis for amikacin, kanamycin and capreomycin.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01724.
    PubMed     Text format     Abstract available


  144. YU X, Zeng X, Shi W, Hu Y, et al
    The validation of Cycloserine efficacy in treatment of multidrug-resistant and extensively drug-resistant tuberculosis in Beijing, China.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01824.
    PubMed     Text format     Abstract available


  145. TOP J, Sinnige JC, Brouwer EC, Werner G, et al
    Identification of a novel genomic island associated with vanD-type vancomycin-resistance in six Dutch vancomycin-resistant Enterococcus faecium.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01793.
    PubMed     Text format     Abstract available


  146. HAGER CL, Larkin EL, Long L, Abidi FZ, et al
    In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02319.
    PubMed     Text format     Abstract available


  147. BORDALLO-CARDONA MA, Marcos-Zambrano LJ, Sanchez-Carrillo C, de la Pedrosa EGG, et al
    Mutant prevention concentration and mutant selection window of micafungin and anidulafungin in clinical Candida glabrata isolates.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.01982.
    PubMed     Text format     Abstract available


  148. BHATTACHARYA S, Fries BC
    Enhanced Efflux Pump Activity in Old Candida glabrata.
    Antimicrob Agents Chemother. 2018 Jan 8. pii: AAC.02227.
    PubMed     Text format     Abstract available


  149. VILCHEZE C, Kim J, Jacobs WR Jr
    Vitamin C potentiates the killing of Mycobacterium tuberculosis by the first-line tuberculosis drugs isoniazid and rifampicin in mice.
    Antimicrob Agents Chemother. 2018 Jan 3. pii: AAC.02165.
    PubMed     Text format     Abstract available


  150. ALSULTAN A, Furin JJ, Du Bois J, van Brakel E, et al
    Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".
    Antimicrob Agents Chemother. 2017;62.
    PubMed     Text format    


    December 2017
  151. SADER HS, Mendes RE, Duncan LR, Pfaller MA, et al
    Antimicrobial Activity of Dalbavancin Tested against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from United States Medical Centers.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02397.
    PubMed     Text format     Abstract available


  152. DOMPREH A, Tang X, Zhou J, Yang H, et al
    Effect of genetic variation of NAT2 on isoniazid, SLCO1B1, and CES2 on rifampin pharmacokinetics in Ghanaian children with tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.02099.
    PubMed     Text format     Abstract available


  153. ELDESOUKY HE, Mayhoub A, Hazbun TR, Seleem MN, et al
    Reversal of azole resistance in Candida albicans by sulfa antibacterial drugs.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.00701.
    PubMed     Text format     Abstract available


  154. IKEH MAC, Fidel PL Jr, Noverr MC
    Prostaglandin E2 Receptor Antagonist with Antimicrobial Activity Against Methicillin Resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01920.
    PubMed     Text format     Abstract available


  155. JUMAH MTB, Vasoo S, Menon SR, De PP, et al
    Pharmacokinetic/pharmacodynamic (PK/PD) Determinants of Vancomycin Efficacy in Enterococcal Bacteremia.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01602.
    PubMed     Text format     Abstract available


  156. AUNG WW, Ei PW, Nyunt WW, Htwe MM, et al
    Pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis clinical isolates in Myanmar.
    Antimicrob Agents Chemother. 2017 Dec 20. pii: AAC.01984.
    PubMed     Text format     Abstract available


  157. DHINGRA S, Buckey JC, Cramer RA
    Hyperbaric Oxygen Reduces Aspergillus fumigatus Proliferation In Vitro and Influences In Vivo Disease Outcomes.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.01953.
    PubMed     Text format     Abstract available


  158. CARTER GP, Schultz MB, Baines SL, Goncalves da Silva A, et al
    Topical antibiotic use co-selects for the carriage of mobile genetic elements conferring resistance to unrelated antimicrobials in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Dec 11. pii: AAC.02000.
    PubMed     Text format     Abstract available


  159. SARATHY JP, Via LE, Weiner D, Blanc L, et al
    Extreme drug tolerance of Mycobacterium tuberculosis in caseum.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02266.
    PubMed     Text format     Abstract available


  160. CHEN Y, Mallick J, Maqnas A, Sun Y, et al
    Chemogenomic profiling of the fungal pathogen Candida albicans.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02365.
    PubMed     Text format     Abstract available


  161. HOGAN S, O'Gara JP, O'Neill E
    Novel treatment of Staphylococcus aureus device-related infections using fibrinolytic agents.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.02008.
    PubMed     Text format     Abstract available


  162. LEE H, Ahn S, Hwang NY, Jeon K, et al
    Limited Effect of Later-generation Fluoroquinolones in the Treatment of Ofloxacin-resistant and Moxifloxacin-susceptible Multidrug-resistant Tuberculosis.
    Antimicrob Agents Chemother. 2017 Dec 4. pii: AAC.01784.
    PubMed     Text format     Abstract available


    November 2017
  163. DESHPANDE D, Srivastava S, Bendet P, Martin KR, et al
    On the antibacterial and sterilizing effect of benzylpenicillin in tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.02232.
    PubMed     Text format     Abstract available


  164. CHANNABASAPPA S, Durgaiah M, Chikkamadaiah R, Kumar S, et al
    Efficacy of novel anti-staphylococcal ectolysin P128 in a rat model of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 27. pii: AAC.01358.
    PubMed     Text format     Abstract available


  165. PATHIRANA RU, Friedman J, Norris HL, Salvatori O, et al
    Fluconazole Resistant Candida auris is Susceptible to Salivary Histatin 5 Killing and to Intrinsic Host Defenses.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01872.
    PubMed     Text format     Abstract available


  166. BASAS J, Palau M, Ratia C, Luis Del Pozo J, et al
    High-dose daptomycin is effective as an antibiotic-lock therapy in a rabbit model of Staphylococcus epidermidis catheter-related infection.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.01777.
    PubMed     Text format     Abstract available


  167. ABBADI BL, Villela AD, Rodrigues-Junior VS, Subtil FT, et al
    Revisiting activation of and the mechanism of resistance to the compound IQG-607 in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02222.
    PubMed     Text format     Abstract available


  168. ZHENG X, Berti AD, McCrone S, Roch M, et al
    Combination antibiotic exposure selectively alters the development of vancomycin intermediate resistance in Staphylococcus aureus.
    Antimicrob Agents Chemother. 2017 Nov 20. pii: AAC.02100.
    PubMed     Text format     Abstract available


  169. TRUONG J, Veillette JJ, Forland SC
    Outcomes of vancomycin plus a beta-lactam versus vancomycin only for the treatment of methicillin-resistant Staphylococcus aureus bacteremia.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01554.
    PubMed     Text format     Abstract available


  170. DENTI P, Garcia-Prats AJ, Draper HR, Wiesner L, et al
    Levofloxacin population pharmacokinetics in South African children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01521.
    PubMed     Text format     Abstract available


  171. VAN DER LAAN LE, Garcia-Prats AJ, Schaaf HS, Tikiso T, et al
    Pharmacokinetics and drug-drug interactions of lopinavir/ritonavir administered with first and second-line antituberculosis drugs in HIV-infected children treated for multidrug-resistant tuberculosis.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.00420.
    PubMed     Text format     Abstract available


  172. EL-HOSSARY EM, Forstner KU, Francois P, Baud D, et al
    A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-dependent Flavin Nitroreductase.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01510.
    PubMed     Text format     Abstract available


  173. HEYCKENDORF J, Andres S, Koser CU, Olaru ID, et al
    What is resistance? Impact of phenotypic versus molecular drug resistance testing on multi- and extensively drug-resistant tuberculosis therapy.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01550.
    PubMed     Text format     Abstract available


  174. CHANDRA J, Ghannoum MA
    CD101, a Novel Echinocandin Possesses Potent Anti-biofilm Activity Against Early and Mature Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Nov 13. pii: AAC.01750.
    PubMed     Text format     Abstract available


  175. BELLEY A, Arhin FA, Moeck G
    Evaluation of Oritavancin Dosing Strategies against Vancomycin-Resistant Enterococcus faecium Isolates with or without Reduced Susceptibility to Daptomycin in an in vitro Pharmacokinetic/Pharmacodynamic Model.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01873.
    PubMed     Text format     Abstract available


  176. GARDNER SG, Marshall DD, Daum RS, Powers R, et al
    Metabolic Mitigation of Staphylococcus aureus Vancomycin Intermediate-Level Susceptibility.
    Antimicrob Agents Chemother. 2017 Nov 6. pii: AAC.01608.
    PubMed     Text format     Abstract available


    October 2017
  177. SUN Q, Xiao TY, Liu HC, Zhao XQ, et al
    Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01279.
    PubMed     Text format     Abstract available


  178. REFOS JM, Vonk AG, Ten Kate MT, Verbrugh HA, et al
    Chitinase induction prior to caspofungin treatment of experimental invasive aspergillosis in neutropenic rats does not enhance survival.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.00960.
    PubMed     Text format     Abstract available


  179. WILLBY MJ, Wijkander M, Havumaki J, Johnson K, et al
    Detection of Mycobacterium tuberculosis pncA mutations by the NIPRO GenoscholarPZA-TB II as compared to conventional sequencing.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01871.
    PubMed     Text format     Abstract available


  180. ARGUDIN MA, Roisin S, Dodemont M, Nonhoff C, et al
    Mutations at the ribosomal S10 gene in clinical strains of Staphylococcus aureus with reduced susceptibility to tigecycline.
    Antimicrob Agents Chemother. 2017 Oct 30. pii: AAC.01852.
    PubMed     Text format     Abstract available


  181. BERUBE BJ, Parish T
    Combinations of respiratory chain inhibitors have enhanced bactericidal activity against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01677.
    PubMed     Text format     Abstract available


  182. GENESTET C, Ader F, Pichat C, Lina G, et al
    Combined Antibacterial Effect of Isoniazid and Rifampicin on Four Mycobacterium tuberculosis Strains: in Vitro Experiments and Response-Surface Modeling.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01413.
    PubMed     Text format     Abstract available


  183. SAPUTO S, Faustoferri RC, Quivey RG Jr
    Vitamin D compounds are bactericidal against Streptococcus mutans and target the bacitracin-associated efflux system.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01675.
    PubMed     Text format     Abstract available


  184. HOLTAPPELS M, Swinnen E, De Groef L, Wuyts J, et al
    The antifungal activity of oleylphosphocholine (OlPC) on in vitro and in vivo Candida albicans biofilms.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01767.
    PubMed     Text format     Abstract available


  185. SAPUTO S, Faustoferri RC, Quivey RG Jr
    A drug repositioning approach reveals Streptococcus mutans is susceptible to a diverse range of established antimicrobials and non-antibiotics.
    Antimicrob Agents Chemother. 2017 Oct 23. pii: AAC.01674.
    PubMed     Text format     Abstract available


  186. ACCOCEBERRY I, Rougeron A, Biteau N, Chevrel P, et al
    A CTG clade Candida yeast genetically engineered for the genotype-phenotype characterization of azole antifungal resistance in human pathogenic yeasts.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01483.
    PubMed     Text format     Abstract available


  187. BHARDWAJ P, Hans A, Ruikar K, Guan Z, et al
    Reduced chlorhexidine and daptomycin susceptibility in vancomycin-resistant Enterococcus faecium after serial chlorhexidine exposure.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01235.
    PubMed     Text format     Abstract available


  188. JONES D, Elshaboury RH, Munson E, Dilworth TJ, et al
    A Retrospective Analysis of Treatment and Clinical Outcomes among Patients with Methicillin-susceptible Staphylococcus aureus Bloodstream Isolates Possessing Detectable mecA by a Commercial PCR Assay Compared to Patients with Methicillin-resistant Sta
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01396.
    PubMed     Text format     Abstract available


  189. XU J, Tasneen R, Peloquin CA, Almeida DV, et al
    Verapamil increases the bioavailability and efficacy of bedaquiline but not clofazimine in a murine model of tuberculosis.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01692.
    PubMed     Text format     Abstract available


  190. RAFFETIN A, Courbin V, Jullien V, Dannaoui E, et al
    In vitro combination of Isavuconazole with Echinocandins against Azole-Susceptible and -Resistant Aspergillus spp.
    Antimicrob Agents Chemother. 2017 Oct 16. pii: AAC.01382.
    PubMed     Text format     Abstract available


  191. DE WELZEN L, Eldholm V, Maharaj K, Manson AL, et al
    Whole transcriptome and genomic analysis of extensively drug-resistant Mycobacterium tuberculosis clinical isolates identifies downregulation of ethA as a mechanism of ethionamide resistance.
    Antimicrob Agents Chemother. 2017 Oct 9. pii: AAC.01461.
    PubMed     Text format     Abstract available


  192. MOUSAVI SF, Pana M, Feizabadi M, Jalali P, et al
    Diversity of mosaic pbp2x families of penicillin-resistant Streptococcus pneumoniae from Iran and Romania.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01535.
    PubMed     Text format     Abstract available


  193. NAKATANI Y, Opel-Reading HK, Merker M, Machado D, et al
    Role of alanine racemase mutations in Mycobacterium tuberculosis D-cycloserine resistance.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01575.
    PubMed     Text format     Abstract available


  194. HEALEY KR, Nagasaki Y, Zimmerman M, Kordalewska M, et al
    The gastrointestinal tract is a major source of echinocandin drug resistance in a murine model of Candida glabrata colonization and systemic dissemination.
    Antimicrob Agents Chemother. 2017 Oct 2. pii: AAC.01412.
    PubMed     Text format     Abstract available


    September 2017
  195. LIU BH, Lei CW, Zhang AY, Pan Y, et al
    Co-location of the multiresistance gene cfr and the fosfomycin resistance gene fosD on a novel plasmid in Staphylococcus arlettae from chicken farm.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01388.
    PubMed     Text format     Abstract available


  196. BUIL JB, van der Lee HAL, Rijs AJMM, Zoll J, et al
    AGAR-BASED SCREENING FOR AZOLE RESISTANCE IN ASPERGILLUS FUMIGATUS USING VIPcheck: A SINGLE CENTRE EVALUATION.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01250.
    PubMed     Text format     Abstract available


  197. DESAI AV, Kovanda LL, Hope WW, Andes D, et al
    Exposure-Response Relationships for Isavuconazole in Patients with Invasive Aspergillosis and Other Filamentous Fungi.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01034.
    PubMed     Text format     Abstract available


  198. JIMENEZ-ORTIGOSA C, Moore C, Denning DW, Perlin DS, et al
    Emergence of Echinocandin Resistance due to a Point Mutation in the fks1 Gene of Aspergillus fumigatus in a Patient with Chronic Pulmonary Aspergillosis.
    Antimicrob Agents Chemother. 2017 Sep 18. pii: AAC.01277.
    PubMed     Text format     Abstract available


  199. XU W, DeJesus MA, Rucker N, Engelhart CA, et al
    Chemical genomic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01334.
    PubMed     Text format     Abstract available


  200. BERNAL-MARTINEZ L, Gil H, Rivero-Menendez O, Gago S, et al
    Development and validation of a High Resolution Melting Assay to detect azole resistance in Aspergillus fumigatus.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01083.
    PubMed     Text format     Abstract available


  201. KIDWAI S, Park CY, Mawatwal S, Tiwari P, et al
    The dual mechanism of action of 5-Nitro-1,10-Phenanthroline against Mycobacterium tuberculosis.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00969.
    PubMed     Text format     Abstract available


  202. PARK YN, Srikantha T, Daniels KJ, Jacob MR, et al
    A Protocol For Identifying Natural Agents That Selectively Affect Adhesion, Thickness, Architecture, Cellular Phenotypes, ECM and Human White Cell Impenetrability of Candida albicans Biofilms.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01319.
    PubMed     Text format     Abstract available


  203. KONG EF, Tsui C, Kucharikova S, Van Dijck P, et al
    Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.01573.
    PubMed     Text format     Abstract available


  204. METCALFE JZ, Streicher E, Theron G, Colman RE, et al
    Mycobacterium tuberculosis subculture results in loss of potentially clinically relevant heteroresistance.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00888.
    PubMed     Text format     Abstract available


  205. NEGRI CE, Goncalves SS, Sousa ACP, Bergamasco MD, et al
    Triazole resistance is still not emerging in A fumigatus isolates causing invasive aspergillosis in Brazilian patients.
    Antimicrob Agents Chemother. 2017 Sep 11. pii: AAC.00608.
    PubMed     Text format     Abstract available


    August 2017
  206. VALENTINE-KING MA, Brown MB
    Antibacterial Resistance in Ureaplasma species and Mycoplasma hominis Isolates from Urine Cultures in College-aged Females.
    Antimicrob Agents Chemother. 2017 Aug 21. pii: AAC.01104.
    PubMed     Text format     Abstract available


    July 2017
  207. YAMADA K, Saito R, Muto S, Kashiwa M, et al
    Molecular characterization of fluoroquinolone-resistant Moraxella catarrhalis variants generated in vitro by stepwise selection.
    Antimicrob Agents Chemother. 2017 Jul 31. pii: AAC.01336.
    PubMed     Text format     Abstract available


  208. CHOI H, Kim SY, Kim DH, Huh HJ, et al
    Clinical Characteristics and Treatment Outcomes of Patients with Acquired Macrolide-resistant Mycobacterium abscessus Lung Disease.
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.01146.
    PubMed     Text format     Abstract available


  209. CHHIBBER S, Shukla A, Kaur S
    Transfersomal phage cocktail: an effective treatment against methicillin resistant S.aureus (MRSA) mediated Skin and Soft tissue infections (SSTIs).
    Antimicrob Agents Chemother. 2017 Jul 24. pii: AAC.02146.
    PubMed     Text format     Abstract available


  210. GALLAGHER LA, Coughlan S, Black NS, Lalor P, et al
    Tandem amplification of SCCmec can drive high level methicillin resistance in MRSA.
    Antimicrob Agents Chemother. 2017 Jul 17. pii: AAC.00869.
    PubMed     Text format     Abstract available


  211. HEINE HS, Shadomy SV, Boyer AE, Chuvala L, et al
    Evaluation of Combination Drug Therapy for Treatment of Antibiotic Resistant Inhalation Anthrax in a Murine Model.
    Antimicrob Agents Chemother. 2017 Jul 10. pii: AAC.00788.
    PubMed     Text format     Abstract available


  212. HENNEBIQUE A, Bidart M, Jarraud S, Beraud L, et al
    Digital PCR for detection and quantification of fluoroquinolone resistance in Legionella pneumophila.
    Antimicrob Agents Chemother. 2017 Jul 3. pii: AAC.00628.
    PubMed     Text format     Abstract available


    June 2017
  213. MATSUMOTO S, Singley CM, Hoover J, Nakamura R, et al
    Efficacy of Cefiderocol against Carbapenem-resistant Gram-negative bacilli in Immunocompetent Rat Respiratory Tract Infection Models Recreating Human Plasma pharmacokinetics.
    Antimicrob Agents Chemother. 2017 Jun 19. pii: AAC.00700.
    PubMed     Text format     Abstract available


  214. TODD DA, Parlet CP, Crosby HA, Malone CL, et al
    Targeting quorum sensing signal biosynthesis to fight antibiotic resistant infections: Ambuic acid as a model inhibitor.
    Antimicrob Agents Chemother. 2017 Jun 12. pii: AAC.00263.
    PubMed     Text format     Abstract available


    May 2017
  215. LODISE T, Ye MJ, Zhao Q
    Prevalence of Invasive Infections due to Carbapenem-Resistant Enterobacteriaceae Among Adult Patients Across US Hospitals.
    Antimicrob Agents Chemother. 2017 May 30. pii: AAC.00228.
    PubMed     Text format     Abstract available


  216. KUNKEL A, Lewnard JA, Pitzer VE, Cohen T, et al
    Antimicrobial Resistance Risks of Cholera Prophylaxis for United Nations Peacekeepers.
    Antimicrob Agents Chemother. 2017 May 22. pii: AAC.00026.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: